期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Linkage and association mapping of wild soybean(Glycine soja)seeds germinating under salt stress 被引量:1
1
作者 SHI Mei-qi LIAO Xi-liang +5 位作者 YE Qian ZHANG Wei LI Ya-kai javaid akhter bhat KAN Gui-zhen YU De-yue 《Journal of Integrative Agriculture》 SCIE CAS CSCD 2022年第10期2833-2847,共15页
Salinity threatens soybean germination,growth and production.The germination stage is a key period in the life of soybean.Wild soybean contains many genes related to stress resistance that are valuable resources for t... Salinity threatens soybean germination,growth and production.The germination stage is a key period in the life of soybean.Wild soybean contains many genes related to stress resistance that are valuable resources for the genetic improvement of soybean.To identify the genetic loci of wild soybean that are active during seed germination under salt stress,two populations,a soybean interspecific hybrid population comprising 142 lines and a natural population comprising 121 wild soybean accessions,were screened for three germination-related traits in this study.By using single-nucleotide polymorphism(SNP)markers with three salt tolerance indices,25 quantitative trait loci(QTLs),21 significant SNPs(–log_(10)(P)≥4.0)and 24 potential SNPs(3.5<–log_(10)(P)<4.0)were detected by linkage mapping and a genome-wide association study(GWAS)in two environments.The key genetic region was identified based on these SNPs and QTLs.According to the gene functional annotations of the W05 genome and salt-induced gene expression qRT-PCR analysis,GsAKR1 was selected as a candidate gene that responded to salt stress at the germination stage in the wild soybean.These results could contribute to determining the genetic networks of salt tolerance in wild soybean and will be helpful for molecular marker-assisted selection in the breeding of salt-tolerant soybean. 展开更多
关键词 salt tolerance wild soybean QTLS GWAS GsAKR1
下载PDF
Use of Impella cardiac axial flow pump for cardiogenic shock(A newer alternative)-How good is the evidence?
2
作者 RAFIQ AHMED bhat SYED MANZOOR ALI +12 位作者 YOOSUF ALI ASHRAF MUHAMMAD HUSSENBOCUS AKANKSHA RATHI javaid akhter bhat ABDUL ALEEM KHAN SYED MAQBOOL RAJA SAQIB IQBAL MD MONOWARUL ISLAM YONGSHENG QU YOU ZHANG YUXIAO SUN WENTAO XIAO ABHISHEK TIBREWAL CHUANYU GAO 《BIOCELL》 SCIE 2022年第5期1139-1150,共12页
The adverse outcomes of a ventricular heart failure(left,right or biventricular)caused by cardiogenic shock are aggravated by lung oedema and organ mal perfusion.Despite advances in medical sciences,revascularisation ... The adverse outcomes of a ventricular heart failure(left,right or biventricular)caused by cardiogenic shock are aggravated by lung oedema and organ mal perfusion.Despite advances in medical sciences,revascularisation and mechanical hemodynamic support have proved ineffective in reducing the mortality rate in such patients.A thorough study of the data available about cardio-vascular diseases reveals that the application of conventional methods of treatment are least helpful to practically restore normal functions of heart when it experiences end-stage systolic ventricular failure.Thus,to overcome the challenges and find alternatives to address this issue,percutaneous ventricular support devices/machines were designed and successfully introduced.These devices have revolutionized the treatment of ventricular heart failures and are now in use all over the world.In this review paper a newer mechanical circulatory support(MCS)device,Impella,has been discussed and compared with a few other devices like(Intra-aortic Balloon Pump(IABP),Extracorporeal Circulation(ECLS)and Veno-arterial Extracorporeal Membrane Oxygenation(VA-ECMO).This article studies the challenges being faced during the treatment of cardiogenic shock,and thoroughly discusses the use and effectiveness of Impella Cardiac Axial Pump in each emergency.It can be said that mechanical circulatory support(MCS)device use during percutaneous coronary intervention(PCI)should be individualized based on multiple factors with a recommended use in patients with the greatest potential benefit and a relatively low risk of device-related complications.The current literature suggests that the outcomes of use of Impella and other mechanical circulatory support devices like IABP and VA-ECMO are comparable.Though there seem to be a few advantages of Impella over the others,sufficiently powered,multi-centric,randomised control trials are needed to establish its superiority. 展开更多
关键词 Cardiogenic shock Hemodynamic support Impella Cardiac Axial Pump IABP VA-ECMO
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部